Approval · Notice of Compliance 27961 · 2022
SENSORCAINE: Notice of Compliance 27961
Issued April 13, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27961
- Date
- April 13, 2022
- Company
- Aspen Pharmacare Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph and conversion to 2020 product monograph format
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SENSORCAINE | Not yet assigned | — |
| SENSORCAINE WITH EPINEPHRINE | Not yet assigned | — |
Medicinal ingredients
- BUPIVACAINE HYDROCHLORIDE 2.5 MG per ML
- BUPIVACAINE HYDROCHLORIDE 5 MG per ML